Medifast Statistics
Share Statistics
Medifast has 10.94M shares outstanding. The number of shares has increased by 0.41% in one year.
Shares Outstanding | 10.94M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | n/a |
Shares Floating | 10.61M |
Failed to Deliver (FTD) Shares | 30 |
FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 1.65M, so 15.12% of the outstanding shares have been sold short.
Short Interest | 1.65M |
Short % of Shares Out | 15.12% |
Short % of Float | 15.58% |
Short Ratio (days to cover) | 11.03 |
Valuation Ratios
The PE ratio is 7.36 and the forward PE ratio is 64.7.
PE Ratio | 7.36 |
Forward PE | 64.7 |
PS Ratio | 0.68 |
Forward PS | 0.4 |
PB Ratio | 3.63 |
P/FCF Ratio | 5.18 |
PEG Ratio | n/a |
Enterprise Valuation
Medifast Inc. has an Enterprise Value (EV) of 659.19M.
EV / Earnings | 6.63 |
EV / Sales | 0.61 |
EV / EBITDA | 4.73 |
EV / EBIT | 5.22 |
EV / FCF | 4.67 |
Financial Position
The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.03.
Current Ratio | 2.43 |
Quick Ratio | 1.84 |
Debt / Equity | 0.03 |
Total Debt / Capitalization | 2.84 |
Cash Flow / Debt | 25.09 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.49% and return on capital (ROIC) is 43.66%.
Return on Equity (ROE) | 0.49% |
Return on Assets (ROA) | 0.32% |
Return on Capital (ROIC) | 43.66% |
Revenue Per Employee | 1.69M |
Profits Per Employee | 156.81K |
Employee Count | 634 |
Asset Turnover | 3.46 |
Inventory Turnover | 5.43 |
Taxes
Income Tax | 29.38M |
Effective Tax Rate | 0.23 |
Stock Price Statistics
The stock price has increased by -71.93% in the last 52 weeks. The beta is 1.16, so Medifast 's price volatility has been higher than the market average.
Beta | 1.16 |
52-Week Price Change | -71.93% |
50-Day Moving Average | 18.75 |
200-Day Moving Average | 23.35 |
Relative Strength Index (RSI) | 55.06 |
Average Volume (20 Days) | 195.72K |
Income Statement
In the last 12 months, Medifast had revenue of $1.07B and earned $99.42M in profits. Earnings per share was $9.13.
Revenue | 1.07B |
Gross Profit | 775.85M |
Operating Income | 126.40M |
Net Income | 99.42M |
EBITDA | 139.51M |
EBIT | 126.40M |
Earnings Per Share (EPS) | 9.13 |
Balance Sheet
The company has $94.44M in cash and $22.01M in debt, giving a net cash position of $72.43M.
Cash & Cash Equivalents | 94.44M |
Total Debt | 22.01M |
Net Cash | 72.43M |
Retained Earnings | 174.65M |
Total Assets | 291.24M |
Working Capital | 152.60M |
Cash Flow
In the last 12 months, operating cash flow was $147.66M and capital expenditures -$6.48M, giving a free cash flow of $141.17M.
Operating Cash Flow | 147.66M |
Capital Expenditures | -6.48M |
Free Cash Flow | 141.17M |
FCF Per Share | 12.97 |
Margins
Gross margin is 72.37%, with operating and profit margins of 11.79% and 9.27%.
Gross Margin | 72.37% |
Operating Margin | 11.79% |
Pretax Margin | 12.01% |
Profit Margin | 9.27% |
EBITDA Margin | 13.01% |
EBIT Margin | 11.79% |
FCF Margin | 13.17% |
Dividends & Yields
MED pays an annual dividend of $4.95, which amounts to a dividend yield of 24.57%.
Dividend Per Share | $4.95 |
Dividend Yield | 24.57% |
Dividend Growth (YoY) | 0% |
Payout Ratio | 738.81% |
Earnings Yield | 47.65% |
FCF Yield | 67.35% |
Analyst Forecast
The average price target for MED is $17, which is -11.3% lower than the current price. The consensus rating is "Hold".
Price Target | $17 |
Price Target Difference | -11.3% |
Analyst Consensus | Hold |
Analyst Count | 1 |
Scores
Altman Z-Score | 5.49 |
Piotroski F-Score | 7 |